Invention Grant
- Patent Title: Method of treatment of attention deficit/hyperactivity disorder (ADHD)
-
Application No.: US17718819Application Date: 2022-04-12
-
Publication No.: US11458143B2Publication Date: 2022-10-04
- Inventor: Christopher D. Breder
- Applicant: Supernus Pharmaceuticals, Inc.
- Applicant Address: US MD Rockville
- Assignee: Supernus Pharmaceuticals, Inc.
- Current Assignee: Supernus Pharmaceuticals, Inc.
- Current Assignee Address: US MD Rockville
- Agency: Foley & Lardner LLP
- Main IPC: A61K31/5375
- IPC: A61K31/5375 ; A61K31/00
Abstract:
The invention comprises a method for treatment of ADHD or ADHD-related disorders by a pharmaceutical agent exhibiting combined serotonergic or noradrenergic reuptake transporters and monoamine receptor activity.
Public/Granted literature
- US20220233548A1 METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) Public/Granted day:2022-07-28
Information query
